Patti Weston, PhD

Director Medical Science Liaison at BioXcel Therapeutics

Patti Weston, PhD has extensive work experience in the healthcare industry. Patti currently works as the Director Medical Science Liaison at BioXcel Therapeutics, Inc. Prior to this, they served as a Clinical Trial Liaison at The Medical Affairs Company (TMAC), supporting clinical trials for Alexion Pharmaceuticals Inc. in the area of rare neurological diseases. Patti also worked as a Medical Science Liaison - Regional Medical Scientist at Indivior, where they developed relationships with key opinion leaders in Addiction and Schizophrenia therapeutic area and engaged in scientific discussions with healthcare professionals. Earlier in their career, they held roles as a Brand Manager and Clinical Liaison - Pharmaceutical Sales Representative at Reckitt Benckiser Pharmaceuticals Inc, a subsidiary of Indivior PLC. Patti was also the Director of Milwaukee Research Programs at the University of Wisconsin - Center for Tobacco Research and Intervention, where they managed research professionals and conducted clinical research trials. Additionally, they worked as a Project Coordinator at the Medical College of Wisconsin, Center for Aids Intervention Research, and as a Licensed Clinical Psychotherapist at Aurora Psychiatric Hospital.

Patti Weston, PhD, has a diverse education history that includes a doctoral degree in Health/Medical Psychology from Northcentral University. Patti completed this degree in 2019. Prior to their PhD, Patti obtained a Master's degree in Clinical/Medical Social Work from the University of Wisconsin-Milwaukee. Additionally, they received a Marketing Strategy Certificate from Cornell University, showing their interest in the field of Marketing/Marketing Management, General. The exact start and end years for their education at Cornell University and the University of Wisconsin-Milwaukee were not specified.

Links

Previous companies

The Medical Affairs Company logo
Indivior logo

Timeline

  • Director Medical Science Liaison

    January, 2021 - present